Inventor · disambiguated record
Majed Fawaz
Also filed as: FAWAZ MAJED
11 granted patents·10 pending applications·172 citations·filing 1999–2025
90Inventor score
Files withVERTEX PHARMA10ATAI THERAPEUTICS INC4EMPATHBIO INC3ATAI Life Sciences AG2ATAI Therapeutics AG1
Top patents by PatentIndex Score
21 records- 0196US8883206B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2014·Granted Nov 11, 2014·83 cites·10 claims
- 0295US10272046B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2016·Granted Apr 30, 2019·27 cites·23 claims
- 0394US11752106B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2021·Granted Sep 12, 2023·3 cites·20 claims
- 0493US11147770B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2019·Granted Oct 19, 2021·6 cites·22 claims
- 0593US9701639B2Co-crystals of modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Jul 11, 2017·41 cites·21 claims
- 0689US2025255819A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0788US12128027B2N—N-dimethyltryptamine (DMT) and DMT analog compositions, methods of making, and methods of use thereofATAI THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·4 cites·20 claims
- 0888US11993577B2Synthesis of MDMA or its optically active (R)- or (S)-MDMA isomersEMPATHBIO INC·Filed 2022·Granted May 28, 2024·2 cites·32 claims
- 0986US12214083B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2023·Granted Feb 4, 2025·0 cites·20 claims
- 1085US12378194B2N, n-dimethyltryptamine salts and crystalline salt formsATAI THERAPEUTICS INC·Filed 2022·Granted Aug 5, 2025·2 cites·16 claims
- 1171US12492178B2Stable polymorph of R-MDMA HClEMPATHBIO INC·Filed 2023·Granted Dec 9, 2025·0 cites·11 claims
- 1271US2025388538A1N,n-dimethyltryptamine salts and crystalline salt formsATAI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1365US2024217944A1Salt forms of r-mdma and methods using the sameATAI Therapeutics AG·Filed 2023·Application pending·0 cites
- 1465US2015024047A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 1561US2024208920A1Synthesis of mda or its optically active (r)- or (s)-mda isomersEMPATHBIO INC·Filed 2023·Application pending·0 cites
- 1661US2013224293A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 1758US2024199544A1Crystalline forms of n,n-dimethyltryptamine and methods of using the sameATAI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1857US2015246031A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 1957US2023270714A1Salvinorin compositionsATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 2050US2023109467A1Preparation of optically active enantiomers of piperonyl amines by resolution of the diastereomeric saltsATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 2132US6132779AMethod for removing cellulosic casings from sausagesVISKASE CORP·Filed 1999·Granted Oct 17, 2000·4 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Majed Fawaz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →